An overview of medicated shampoos used in dandruff treatment

P and T

Volumn 31, Issue 7, 2006, Pages 396-400

  Sanfilippo, Angela ^a   English III, Joseph C ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; BAKER P AND S; CICLOPIROXOLAMINE; CINNAMIC ACID; CLOBETASOL PROPIONATE; CLOBEX; DANDREX; DHS TAR; DHS ZINC; ECONAZOLE; ELUBIOL; EXSEL 2.5%; FLEX; HEAD AND SHOULDERS INTENSIVE TREATMENT; HYDROXYPYRIDONE DERIVATIVE; IMIDAZOLE DERIVATIVE; IONIL PLUS; IONIL T; KERATOLYTIC AGENT; KETOCONAZOLE; MG 217 TAR FREE SHAMPOO; PENTRAX; PIROCTONE ETHANOLAMINE; POLYTAR; PYRITHIONE ZINC; PYRITHIONE ZINC PLUS SELENIUM SULFIDE; REME T; SALICYLIC ACID; SEBULEX; SEBULON; SEBUTONE; SELENIUM SULFIDE; SELENIUM SULFIDE 1%; SELENIUM SULFIDE 2.5%; SELSEB; SELSUN 2.5%; SHAMPOO; STEROID; STIEPROX; SULFUR; T GEL; T SAL; TAR; TARSUM; TEA TREE OIL; TEGRIN; TERPINEN 4 OL; THERAPLEX Z; UNCLASSIFIED DRUG; X SEB T PLUS; ZETAR; ZINC; ZINCON; ZNP BAR;

ALTERNATIVE MEDICINE; CLINICAL TRIAL; DANDRUFF; DRUG EFFICACY; DRUG FORMULATION; DRUG MECHANISM; DRUG SAFETY; ERYTHEMA; HONEY; HUMAN; KERATINIZATION; MAINTENANCE THERAPY; MALASSEZIA; OILY SKIN; PATHOGENESIS; PRESCRIPTION; PRURITUS; REVIEW; SKIN IRRITATION; SYMPTOMATOLOGY;

EID: 33746639572     PISSN: 10521372     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. Pierard-Franchimont C, Hermanns JH, Degreef H, Pierard GE. From axioms to new insights into dandruff. Dermatology 2000; 200:93-98.
2. Gupta AK, Batra R, Bluhm R, et al. Skin diseases associated with Malassezia species. J Am Acad Dermatol 2004;51(5):785-798.
3. Faergemann J. Pityrosporum species as a cause of allergies and infections. Allergy 1999;54:413-419.
4. Schmidt A. Malassezia furfur: A fungus belonging to the physiological skin flora and its relevance in skin disorders. Cutis 1997;59(1):21-24.
5. Brodell RT, Cooper KD. Therapeutic shampoos. In: Wolverton SE, ed. Comprehensive Dermatologic Drug Therapy. Philadelphia, PA: WB Saunders Company; 2001:647-658.
6. Baden HP, Baden LA. Keratolytic agents. In: Freedberg IM, Eisen AZ, Wolff K, et al., eds. Fitzpatrick's Dermatology in General Medicine, 6th ed, vol 2. New York: McGraw-Hill; 2003:2352-2355.
7. Shapiro J, Maddin S. Medicated shampoos. Clin Dermatol 1996; 14:123-128.
8. Bamford JT. Treatment of tinea versicolor with sulfur-salicylic shampoo. J Am Acad Dermatol 1983;8(2):211-213.
9. Lin AN, Reimer RJ, Carter DM. Sulfur revisited. J Am Acad Dermatol 1988;18:553-558.
10. Gupta AK, Nicol K. The use of sulfur in dermatology. J Drugs Dermatol 2004;3(4):427-431.
11. Leyden JJ, McGinley KJ, Mills OH, et al. Effects of sulfur and salicylic acid in a shampoo base in the treatment of dandruff: A double-blind study using corneocyte counts and clinical grading. Cutis 1987;39(6):557-561.
12. Marks R, Pearse A. The effects of a shampoo containing zinc pyrithione on the control of dandruff. Br J Dermatol 1985;112: 415-422.
13. Gibson W, Hardy W, Groom M. The effect and mode of action of zinc pyrithione on cell growth: II. In vivo studies. Food Chem Toxicol 1985;23(11):103-110.
14. Warner RR, Schwartz JR, Boissy Y, Dawson TL. Dandruff has an altered stratum corneum ultrastructure that is improved with zinc pyrithione shampoo. J Am Acad Dermatol 2001;45(6):897-903.
15. Robinson JR, Gauger LJ. Dermatitis, dry skin, dandruff, seborrheic dermatitis and psoriasis products. In: Nonprescription Products, Formulations, and Features, 8th ed. Washington, DC: American Pharmaceutical Association; 1986;30:597-623.
16. Lowe NJ, Stoughton RB, McCulough JL, Weinstein GD: Topical drugs on normal and proliferating cell models: Comparison with responses in psoriatics. Arch Dermatol 1981;117:394-398.
17. Pierard-Franchimont C, Pierard GE, Vroome V, Lin GC, Appa Y. Comparative anti-dandruff efficacy between a tar and a non-tar shampoo. Dermatology 2000;200(2):181-184.
18. Milani M, Antonio Di Molfetta S, Gramazio R, et al. Efficacy of betamethasone valerate 0.1% thermophobic foam in seborrheic dermatitis of the scalp: An open-label, multicentre prospective trial on 180 patients. Curr Med Res Opin 2003;19(4):342-345.
19. Shuster S. The aetiology of dandruff and the mode of action of therapeutic agents. Br J Dermatol 1984;3:235-242.
20. Danby FW, Maddin WS, Margesson LJ, Rosenthal D. A randomized, double-blind, placebo-controlled trial of ketoconazole 2% shampoo versus selenium sulfide 2.5% shampoo in the treatment of moderate to severe dandruff. J Am Acad Dermatol 1993;29(6): 1008-1012.
21. Pierard-Franchimont C, Pierard GE. Subjects using antidandruff shampoos. J Eur Acad Dermatol Venereol 1995;5:S153.
22. Rapaport M. A randomized, controlled clinical trial of four anti-dandruff shampoos. J Int Med Res 1981;9(2):152-156.
23. Van Cutsem J, Van Gerven F, Fransen J, et al. The in vitro antifungal activity of ketoconazole, zinc pyrithione, and selenium sulfide against Pityrosporum guinea pigs. J Am Acad Dermatol 1990;22:993-998.
24. Cauwenbergh G, De Doncker P, Schrooten P, et al. Treatment of dandruff with a 2% ketoconazole scalp gel: A double-blind placebo-controlled study. Int J Dermatol 1986;25:541.
25. Vanden Bossche H. Mode of action of pyridine, pyrimidine, and azole antifungals. In: Berg G, Plempel M, eds. Sterol Biosynthesis Inhibitors. Chichester, England: Ellis Horwood Ltd.; 1988:79.
26. Vanden Bossche H, Marichal P. Mode of action of anti-Candida drugs: Focus on terconazole and other ergosterol biosynthesis inhibitors. Am J Obstet Gynecol 1991;165:1193-1199.
27. Hoing M, De Dier A, Schuermann V, Cauwenbergh G. Ketoconazole shampoo in the treatment of dandruff and/or seborrheic dermatitis: A combined analysis of 10 clinical trials on 518 patients. Beerse, Belgium: Janssen Pharmaceutica; 1987.
28. Thulliez M, Schiettekatte L, et al. Comparison of four concentrations of ketoconazole shampoo with placebo shampoo in dandruff or seborrheic dermatitis. Beerse, Belgium: Janssen Pharmaceutica; 1987.
29. Van Derheyden D, Cauwenberg G, Thulliez M, et al. Ketoconazole shampoo in the treatment of dandruff and/or seborrheic dermatitis: A randomized, double-blind, placebo-controlled comparison of different concentrations. Beerse, Belgium: Janssen Pharmaceutica; 1987.
30. Pierard-Franchimont C, Goffin V, Decroix J, Pierard GE. A multi-center randomized trial of ketoconazole 2% and zinc pyrithione 1% shampoos in severe dandruff and seborrheic dermatitis. Skin Pharmacol Appl Skin Physiol 2002;15(6):434-441.
31. Saple DG, Ravichandran G, Desai A. Evaluation of safety and efficacy of ketoconazole 2% and zinc pyrithione 1% shampoo in patients with moderate to severe dandruff: A postmarketing study. J Indian Med Assoc 2000;98(12):810-811.
32. Del Palacio-Hernanz A, Guarro-Artigas J, Figueras-Salvat MJ, et al: Changes in fungal ultrastructure after short-course ciclopirox olamine therapy in pityriasis versicolor. Clin Exp Dermatol 1990; 15:95-100.
33. Nahm WK, Orengo I, Rosen T. The antifungal agent butenafine manifests anti-inflammatory activity in vivo. J Am Acad Dermatol 1999;41:203-206.
34. Lee JH, Lee HS, Eun HC, Cho KH. Successful treatment of dandruff with 1.5% ciclopirox olamine shampoo in Korea. J Dermatol Treat 2003;14:212-215.
35. Altmeyer P, Hoffman K. Loprox Shampoo Dosing Concentration Study Group. Efficacy of different concentrations of ciclopirox shampoo for the treatment of seborrheic dermatitis of the scalp: Results of a randomized, double-blind, vehicle-controlled trial. Int J Dermatol 2004;43(Suppl 1):9-12.
36. Squire R, Goode K. A randomized, single-blind, single-center clinical trial to evaluate comparative clinical efficacy of shampoos containing ciclopirox olamine (1.5%) and salicylic acid (3%), or ketoconazole (2%) for the treatment of dandruff/seborrheic dermatitis. J Dermatol Treat 2002;13(2):51-60.
37. Nenoff P, Haustein UF, Brandt W. Antifungal activity of the essential oil of Melaleuca alternifolia (tea tree oil) against pathogenic fungi in vitro. Skin Pharmacol 1996;9(6):388-394.
38. Carson CF, Riley TV. Antimicrobial activity of the major components of the essential oil of Melaleuca alternifolia. J Appl Bacteriol 1995; 78:264-269.
39. Satchell AC, Saurajen A, Bell C, Barnetson RS. Treatment of dandruff with 5% tea tree oil shampoo. J Am Acad Dermatol 2002; 47(6):852-855.
40. Baroni A, DeRosa R, DeRosa A. New strategies in dandruff treatment: Growth control of Malassezia ovalis. Dermatology 2000; 201(4):332-336.
41. Gupta AK, Nicol K, Batra R. Role of antifungal agents in the treatment of seborrheic dermatitis. Am J Clin Dermatol 2004;5(6):417-422.